Literature DB >> 17986629

Mitochondrial adaptations to steatohepatitis induced by a methionine- and choline-deficient diet.

Caroline Romestaing1, Marie-Astrid Piquet, Dominique Letexier, Benjamin Rey, Arnaud Mourier, Stéphane Servais, Maud Belouze, Vincent Rouleau, Marianne Dautresme, Isabelle Ollivier, Roland Favier, Michel Rigoulet, Claude Duchamp, Brigitte Sibille.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) has become common liver disease in Western countries. There is accumulating evidence that mitochondria play a key role in NAFLD. Nevertheless, the mitochondrial consequences of steatohepatitis are still unknown. The bioenergetic changes induced in a methionine- and choline-deficient diet (MCDD) model of steatohepatitis were studied in rats. Liver mitochondria from MCDD rats exhibited a higher rate of oxidative phosphorylation with various substrates, a rise in cytochrome oxidase (COX) activity, and an increased content in cytochrome aa3. This higher oxidative activity was associated with a low efficiency of the oxidative phosphorylation (ATP/O, i.e., number of ATP synthesized/natom O consumed). Addition of a low concentration of cyanide, a specific COX inhibitor, restored the efficiency of mitochondria from MCDD rats back to the control level. Furthermore, the relation between respiratory rate and protonmotive force (in the nonphosphorylating state) was shifted to the left in mitochondria from MCDD rats, with or without cyanide. These results indicated that, in MCDD rats, mitochondrial ATP synthesis efficiency was decreased in relation to both proton pump slipping at the COX level and increased proton leak although the relative contribution of each phenomenon could not be discriminated. MCDD mitochondria also showed a low reactive oxygen species production and a high lipid oxidation potential. We conclude that, in MCDD-fed rats, liver mitochondria exhibit an energy wastage that may contribute to limit steatosis and oxidative stress in this model of steatohepatitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986629     DOI: 10.1152/ajpendo.00407.2007

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  16 in total

1.  Experimental models of non-alcoholic fatty liver disease in rats.

Authors:  Otto Kucera; Zuzana Cervinkova
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) effect on glucose production, but not energy metabolism, is independent of hepatic AMPK in vivo.

Authors:  Clinton M Hasenour; D Emerson Ridley; Curtis C Hughey; Freyja D James; E Patrick Donahue; Jane Shearer; Benoit Viollet; Marc Foretz; David H Wasserman
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

3.  Disruption of hepatic one-carbon metabolism impairs mitochondrial function and enhances macrophage activity in methionine-choline-deficient mice.

Authors:  Brandon J Eudy; Caitlin E McDermott; Gabriel Fernandez; Clayton E Mathews; Jinping Lai; Robin P da Silva
Journal:  J Nutr Biochem       Date:  2020-03-19       Impact factor: 6.048

Review 4.  The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.

Authors:  Jung Sub Lim; Michele Mietus-Snyder; Annie Valente; Jean-Marc Schwarz; Robert H Lustig
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-04-06       Impact factor: 46.802

Review 5.  NAFLD and diabetes mellitus.

Authors:  Herbert Tilg; Alexander R Moschen; Michael Roden
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-10-12       Impact factor: 46.802

6.  Early septic shock induces loss of oxidative phosphorylation yield plasticity in liver mitochondria.

Authors:  Pierre Eyenga; Damien Roussel; Jérôme Morel; Benjamin Rey; Caroline Romestaing; Loic Teulier; Shey-Shing Sheu; Joelle Goudable; Claude Négrier; Jean Paul Viale
Journal:  J Physiol Biochem       Date:  2014-02-26       Impact factor: 4.158

7.  Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly.

Authors:  Jorge Simon; Maitane Nuñez-García; Pablo Fernández-Tussy; Lucía Barbier-Torres; David Fernández-Ramos; Beatriz Gómez-Santos; Xabier Buqué; Fernando Lopitz-Otsoa; Naroa Goikoetxea-Usandizaga; Marina Serrano-Macia; Rubén Rodriguez-Agudo; Maider Bizkarguenaga; Imanol Zubiete-Franco; Virginia Gutiérrez-de Juan; Diana Cabrera; Cristina Alonso; Paula Iruzubieta; Manuel Romero-Gomez; Sebastiaan van Liempd; Azucena Castro; Ruben Nogueiras; Marta Varela-Rey; Juan Manuel Falcón-Pérez; Erica Villa; Javier Crespo; Shelly C Lu; Jose M Mato; Patricia Aspichueta; Teresa C Delgado; María Luz Martínez-Chantar
Journal:  Cell Metab       Date:  2020-02-21       Impact factor: 27.287

8.  Role of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet.

Authors:  Rebecca C Schugar; Xiaojing Huang; Ashley R Moll; Elizabeth M Brunt; Peter A Crawford
Journal:  PLoS One       Date:  2013-08-29       Impact factor: 3.240

9.  Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis.

Authors:  David P Macfarlane; Xiantong Zou; Ruth Andrew; Nicholas M Morton; Dawn E W Livingstone; Rebecca L Aucott; Moffat J Nyirenda; John P Iredale; Brian R Walker
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-11-30       Impact factor: 4.310

10.  Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats.

Authors:  Zheng-Jie Xu; Jian-Gao Fan; Xiao-Dong Ding; Liang Qiao; Guo-Liang Wang
Journal:  Dig Dis Sci       Date:  2009-05-21       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.